Ipek Ilgin Gönenc

Ipek Ilgin Gönenc

Auto-generated profile, based on publicly available information

Ipek Ilgin Gönenc

Institute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2022 in Clinical Genetics
Verified
Journal Article
Open access
IGIpek Ilgin Gönenc
Ipek Ilgin Gönenc
NENursel H. Elcioglu
Nursel H. Elcioglu
CGCarolina Martinez Grijalva
Carolina Martinez Grijalva
SASeda Aras
Seda Aras
NGNadine Großmann
Nadine Großmann
BWBernd Wollnik
Bernd Wollnik
Bloom syndrome (BS) is an autosomal recessive disorder with characteristic clinical features of primary microcephaly, growth deficiency, cancer predisposition, and immunodeficiency. Here, we report the clinical and molecular findings of eight patients from six families diagnosed with BS. We identified causative pathogenic variants in all families including three different variants in BLM and one variant in RMI1. The homozygous c.581_582delTT;p.Phe194* and c.3164G>C;p.Cys1055Ser variants in BLM have already been reported in BS patients, while the c.572_573delGA;p.Arg191Lysfs*4 variant is novel. Additionally, we present the detailed clinical characteristics of two cases with BS in which we previously identified the biallelic loss‐of‐function variant c.1255_1259delAAGAA;p.Lys419Leufs*5 in RMI1. All BS patients had primary microcephaly, intrauterine growth delay, and short stature, presenting the phenotypic hallmarks of BS. However, skin lesions and upper airway infections were observed only in some of the patients. Overall, patients with pathogenic BLM variants had a more severe BS phenotype compared to patients carrying the pathogenic variants in RMI1, especially in terms of immunodeficiency, which should be considered as one of the most important phenotypic characteristics of BS.

31 January 2022 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
IGIpek Ilgin Gönenc
Ipek Ilgin Gönenc
AWAlexander Wolff
Alexander Wolff
JSJulia Schmidt
Julia Schmidt
AZArne Zibat
Arne Zibat
CMChristian Müller
Christian Müller
BWBernd Wollnik
Bernd Wollnik
Bloom syndrome (BS) is an autosomal recessive disease clinically characterized by primary microcephaly, growth deficiency, immunodeficiency and predisposition to cancer. It is mainly caused by biallelic loss-of-function mutations in the BLM gene, which encodes the BLM helicase, acting in DNA replication and repair processes. Here, we describe the gene expression profiles of three BS fibroblast cell lines harboring causative, biallelic truncating mutations obtained by single-cell (sc) transcriptome analysis. We compared the scRNA transcription profiles from three BS patient cell lines to two age-matched wild-type controls and observed specific deregulation of gene sets related to the molecular processes characteristically affected in BS, such as mitosis, chromosome segregation, cell cycle regulation and genomic instability. We also found specific upregulation of genes of the Fanconi anemia pathway, in particular FANCM, FANCD2 and FANCI, which encode known interaction partners of BLM. The significant deregulation of genes associated with inherited forms of primary microcephaly observed in our study might explain in part the molecular pathogenesis of microcephaly in BS, one of the main clinical characteristics in patients. Finally, our data provide first evidence of a novel link between BLM dysfunction and transcriptional changes in condensin complex I and II genes. Overall, our study provides novel insights into gene expression profiles in BS on an sc level, linking specific genes and pathways to BLM dysfunction.

22 April 2025 in bioRxiv
Verified
Preprint
Open access
IGIpek Ilgin Gönenç
Ipek Ilgin Gönenç
AWAlexander Wolff
Alexander Wolff
ABAlexandra Viktoria Busley
Alexandra Viktoria Busley
AWAngela Wieland
Angela Wieland
ATAndrea Tijhuis
Andrea Tijhuis
BWBernd Wollnik
Bernd Wollnik
Biallelic loss-of-function (LoF) variants in the BTRR complex members BLM , TOP3A, RMI1, and RMI2 cause Bloom syndrome (BS). The BTRR complex mainly acts on DNA replication and DNA repair processes, and dysfunction of this complex underlies, e.g., increased genomic instability and cancer predisposition associated with the BS phenotype. Here, we report CRISPR/Cas9-based genome-edited isogenic induced pluripotent stem cell (iPSC) models with compound heterozygous LoF variants in BLM, TOP3A , and RMI1 . The cellular phenotype of all three knockout (KO) iPSC lines included chromosome segregation defects, increased sister chromatid exchange rates, and impaired homologous recombination repair. Using single-cell whole genome sequencing, we showed that BTRR complex deficiency causes increased copy number alterations (CNAs) in the genomes and, therefore, represents a driver for genomic instability. CNA load was further induced by applying replication stress, and we observed that BTRR KO iPSCs acquired fewer de novo CNA events compared to wild-type cells, suggesting a possible limitation of genomic instability induction. Importantly, induced and non-induced CNAs in single-cell genomes were not stochastically distributed throughout the genome, but instead enriched at fragile sites. This finding might offer an opportunity for the development of novel NGS-based approaches to measure rates of genomic instability in disease conditions.

10 September 2025 in bioRxiv
Verified
Preprint
Open access
KTKaima Tsukada
Kaima Tsukada
LLLiudmyla Lototska
Liudmyla Lototska
ATAya Tsukada
Aya Tsukada
IGIpek Ilgin Gönenç
Ipek Ilgin Gönenç
CSCharlotte Sherlaw-Sturrock
Charlotte Sherlaw-Sturrock
ABAndrew N. Blackford
Andrew N. Blackford
SUMMARY: DNA double-strand breaks and unresolved DNA replication intermediates are particularly dangerous during mitosis. Paradoxically, cells inactivate canonical DNA repair mechanisms during chromosome segregation in favor of alternative pathways that depend on TOPBP1 and CIP2A, but how they function is still poorly defined. Here, we describe the identification of DDIAS as a mitosis-specific DNA damage response protein. We establish DDIAS as a phosphorylation-dependent component and effector of the TOPBP1-CIP2A complex with single-stranded DNA (ssDNA)-binding activity, and thereby delineate a ssDNA protection mechanism that safeguards chromosome integrity during mitosis, particularly in BRCA-deficient cells. We also identify biallelic inactivating mutations in DDIAS and CIP2A in patients with severe neurodevelopmental phenotypes. These findings highlight the physiological importance of the DNA damage response in mitosis, and may open new avenues for synthetic-lethal therapy in BRCA-deficient cancers.

1 March 2026 in Genes & Diseases
Verified
Journal Article
Open access
MMMaría José Muñoz
María José Muñoz
Alejandro Cabrera-AndradeAlejandro Cabrera-Andrade
Alejandro Cabrera-Andrade
AGAne Gutierrez-Aguirregabiria
Ane Gutierrez-Aguirregabiria
IGIpek Ilgin Gönenc
Ipek Ilgin Gönenc
SCSantiago Ramón Y Cajal
Santiago Ramón Y Cajal
Trond AasenTrond Aasen
Trond Aasen

10 November 2021 in medRxiv
Verified
Preprint
Open access
PDF file
IGIpek Ilgin Gönenc
Ipek Ilgin Gönenc
NENursel Elcioglu
Nursel Elcioglu
CGCarolina Martinez Grijalva
Carolina Martinez Grijalva
SASeda Aras
Seda Aras
NGNadine Großmann
Nadine Großmann
BWBernd Wollnik
Bernd Wollnik
Bloom syndrome (BS) is an autosomal recessive disease with characteristic clinical features of primary microcephaly, growth deficiency, skin lesions, cancer predisposition, and immunodeficiency. Here, we report the clinical and molecular findings of eight patients from six families diagnosed with BS. We identified causative mutations in all families, three different homozygous mutations in BLM and one causative homozygous mutation in RMI1 . The homozygous c.581_582delTT (p.Phe194*) and c.3164G>C (p.Cys1055Ser) mutations in BLM have already been reported in BS patients, while the c.572_573delGA (p.Arg191Lysfs*4) is novel. Interestingly, whole-exome sequencing revealed a homozygous loss-of-function mutation in RMI1 in two BS patients of a consanguineous Turkish family. All BS patients had primary microcephaly, intrauterine growth delay, and short stature, presenting the phenotypic hallmarks of BS. However, a narrow face, skin lesions, and upper airway infections were observed only in some of the patients. Overall, patients with homozygous BLM mutations had a more severe BS phenotype compared to patients carrying the homozygous RMI1 mutation, especially in terms of immunodeficiency and associated recurrent infections. Low-level immunoglobulins were observed in all BLM -mutated patients, emphasizing the immunodeficiency profile of the disease, which should be considered as an important phenotypic characteristic of BS, especially in the current Covid-19 pandemic era.